COR-1004
Asset
Investigational agent co-administered with COR-2003 for cardiovascular risk factors
- Stage
- Phase 1
- Modality
- Other
- Target
- Lipid and ceramide metabolism
- 0
- Indications
- 1
- Trial
- 1
- Developer
Indications
1No named disease
Phase 1, Not yet recruiting, NCT07858019, clinicaltrials.gov, 9 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.